People

Morgan Hunter

biomedvc.comlinkedin.com

Morgan Hunter joined Biomed in 2022 and is listed as investment manager with BiomedVC. His earlier entrepreneurial research included the planned ETH Zurich spin-off Emuna Therapeutics. His scientific training covers pharmaceutical immunology, vascular biology and protein engineering. These are institutional manager affiliations; no personal portfolio investment is inferred.